0001209191-23-041087.txt : 20230705
0001209191-23-041087.hdr.sgml : 20230705
20230705163016
ACCESSION NUMBER: 0001209191-23-041087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230705
DATE AS OF CHANGE: 20230705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOYER ANDREW S
CENTRAL INDEX KEY: 0001239546
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38485
FILM NUMBER: 231069586
MAIL ADDRESS:
STREET 1: C/O WATSON PHARMA INC
STREET 2: 360 MOUNT KEMBLE AVE
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001723128
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
BUSINESS PHONE: (908) 947-3120
MAIL ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
STREET 2: 3RD FLOOR
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Atlas Holdings, Inc.
DATE OF NAME CHANGE: 20171117
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-30
0
0001723128
Amneal Pharmaceuticals, Inc.
AMRX
0001239546
BOYER ANDREW S
C/O AMNEAL PHARMACEUTICALS, INC.
BRIDGEWATER
NJ
08807
0
1
0
0
Executive Vice President
0
Class A Common Stock
2023-06-30
4
M
0
23095
A
285612
D
Class A Common Stock
2023-06-30
4
F
0
11571
3.10
D
274041
D
Restricted Stock Units
2023-06-30
4
M
0
23095
0.00
D
Class A Common Stock
23095
0
D
Represents the gross number of shares of Class A Common Stock, par value $0.01 per share (the "Class A Common Stock") issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Represents shares of Class A Common Stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
On August 1, 2020, the reporting person was granted 69,284 restricted stock units vesting in three equal installments beginning on June 30, 2021.
/s/ Chris Daly, Attorney-in-Fact
2023-07-05